topic

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
Dipongkor Saha, Samuel D Rabkin, Robert L Martuza

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000345; DOI: 10.1136/jitc-2019-000345
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
Luca Mazzarella, Stefania Morganti, Antonio Marra, Dario Trapani, Giulia Tini, Piergiuseppe Pelicci, Giuseppe Curigliano

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000475; DOI: 10.1136/jitc-2019-000475
NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma
Rahul Suresh, David J Barakat, Theresa Barberi, Lei Zheng, Elizabeth Jaffee, Kenneth J Pienta, Alan D Friedman

Journal for ImmunoTherapy of Cancer Jan 2020, 8 (1) e000244; DOI: 10.1136/jitc-2019-000244
Biomarkers for immunotherapy for treatment of glioblastoma
John P Lynes, Anthony K Nwankwo, Hannah P Sur, Victoria E Sanchez, Kwadwo A Sarpong, Oluwatobi I Ariyo, Gifty A Dominah, Edjah K Nduom

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000348; DOI: 10.1136/jitc-2019-000348
Management of hepatitis B in the era of checkpoint inhibition
Janice Dutcher

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000276; DOI: 10.1136/jitc-2019-000276
Nanopore sequencing as a scalable, cost-effective platform for analyzing polyclonal vector integration sites following clinical T cell therapy
Ping Zhang, Devika Ganesamoorthy, Son Hoang Nguyen, Raymond Au, Lachlan J Coin, Siok-Keen Tey

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000299; DOI: 10.1136/jitc-2019-000299
Correction: HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000157corr1; DOI: 10.1136/jitc-2019-000157corr1
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
Brenda De Keersmaecker, Sofie Claerhout, Javier Carrasco, Isabelle Bar, Jurgen Corthals, Sofie Wilgenhof, Bart Neyns, Kris Thielemans

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000329; DOI: 10.1136/jitc-2019-000329
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE₂-receptor E-type 4 (EP4), in patients with advanced cancers
David S Hong, Aparna Parikh, Geoffrey I Shapiro, Andrea Varga, Aung Naing, Funda Meric-Bernstam, Özlem Ataman, Larisa Reyderman, Terri A Binder, Min Ren, Mingjie Liu, Satish Dayal, Amy Y Siu, Pallavi Sachdev, Lucy Xu, Vijay Bhagawati-Prasad, Ilian Tchakov, Chean Eng Ooi, Xingfeng Bao, Aurelien Marabelle

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000222; DOI: 10.1136/jitc-2019-000222
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice
Thomas Pilot, Aurélie Fratti, Chloé Thinselin, Anaïs Perrichet, Lucie Demontoux, Emeric Limagne, Valentin Derangère, Alis Ilie, Mané Ndiaye, Elise Jacquin, Carmen Garrido, François Ghiringhelli, Fanny Chalmin, Cédric Rébé

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000478; DOI: 10.1136/jitc-2019-000478

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages